Free Trial

TriMas (NASDAQ:TRS) Updates FY 2025 Earnings Guidance

TriMas logo with Industrials background

Key Points

  • TriMas has updated its FY 2025 earnings guidance, forecasting EPS between $1.950 and $2.100, surpassing the consensus estimate of $1.825, with revenue guidance also above the consensus.
  • Shares of TriMas have experienced a significant rise of 15.4%, with the stock opening at $36.32 after recent positive earnings results exceeding analysts' expectations.
  • The company has announced a quarterly dividend of $0.04 per share, reflecting an annualized yield of 0.44% and a payout ratio of 20.78%, with the payout scheduled for August 12th.
  • MarketBeat previews the top five stocks to own by August 1st.
  • Limited Time Offer: Unlock powerful research tools, advanced financial data, and expert insights to help you invest with confidence. Save 50% when you upgrade to MarketBeat All Access during the month of July. Claim your discount here.

TriMas (NASDAQ:TRS - Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 1.950-2.100 for the period, compared to the consensus estimate of 1.825. The company issued revenue guidance of $999.0 million-$1.0 billion, compared to the consensus revenue estimate of $974.2 million.

TriMas Stock Performance

Shares of TRS traded up $0.83 during midday trading on Wednesday, reaching $35.70. The stock had a trading volume of 1,133,696 shares, compared to its average volume of 347,729. The firm has a market cap of $1.45 billion, a PE ratio of 39.23 and a beta of 0.63. The company has a current ratio of 2.82, a quick ratio of 1.49 and a debt-to-equity ratio of 0.63. The firm has a 50 day simple moving average of $28.55 and a 200-day simple moving average of $25.11. TriMas has a one year low of $19.33 and a one year high of $36.77.

TriMas (NASDAQ:TRS - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The industrial products company reported $0.61 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.50 by $0.11. The firm had revenue of $274.76 million during the quarter, compared to the consensus estimate of $251.18 million. TriMas had a net margin of 3.83% and a return on equity of 11.65%. The business's revenue for the quarter was up 14.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.43 EPS. As a group, sell-side analysts anticipate that TriMas will post 1.69 EPS for the current year.

TriMas Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, August 12th. Shareholders of record on Tuesday, August 5th will be issued a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a yield of 0.45%. The ex-dividend date of this dividend is Tuesday, August 5th. TriMas's payout ratio is 20.78%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on TRS. BWS Financial raised their price objective on shares of TriMas from $40.00 to $45.00 and gave the company a "buy" rating in a research note on Wednesday. Wall Street Zen upgraded shares of TriMas from a "hold" rating to a "buy" rating in a report on Sunday, June 1st.

Read Our Latest Research Report on TriMas

Insiders Place Their Bets

In related news, Director Adrianne Shapira purchased 4,000 shares of the firm's stock in a transaction on Thursday, June 5th. The stock was bought at an average cost of $25.82 per share, with a total value of $103,280.00. Following the completion of the acquisition, the director owned 8,476 shares of the company's stock, valued at $218,850.32. The trade was a 89.37% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Shawn Sedaghat purchased 72,937 shares of the company's stock in a transaction that occurred on Thursday, May 22nd. The shares were purchased at an average price of $26.16 per share, with a total value of $1,908,031.92. Following the completion of the transaction, the director directly owned 1,883,758 shares of the company's stock, valued at $49,279,109.28. This represents a 4.03% increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders acquired 848,261 shares of company stock worth $21,645,007. Insiders own 14.20% of the company's stock.

Institutional Investors Weigh In On TriMas

A hedge fund recently raised its stake in TriMas stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in TriMas Corporation (NASDAQ:TRS - Free Report) by 4.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 24,120 shares of the industrial products company's stock after purchasing an additional 1,014 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned 0.06% of TriMas worth $565,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 99.42% of the company's stock.

About TriMas

(Get Free Report)

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

Featured Stories

Earnings History and Estimates for TriMas (NASDAQ:TRS)

Should You Invest $1,000 in TriMas Right Now?

Before you consider TriMas, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.

While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday
ACT FAST! Congress is Dumping these 3 Stocks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines